Table 3.
Long non-coding RNAs associated with prognosis of osteosarcoma.
| LncRNA Name | Number of OS Sample | Expression Pattern | Prognosis | Ref. |
|---|---|---|---|---|
| HULC | 78 tissue samples | High | Poor | [81] |
| 33 tissue samples | [87] | |||
| MEG3 | 64 tissue samples | Low | Good | [91] |
| HOTTIP | 68 tissue samples | High | Poor | [62] |
| UCA1 | 135 tissue samples | High | Poor | [69] |
| HIF2PUT | 82 tissue samples | High | Poor | [88] |
| BCAR4 | 60 tissue samples | High | Poor | [73] |
| MALAT1 | 162 tissue samples | High | Poor | [89] |
| TUG1 | 76 tissue samples 29 blood samples | High | Poor | [78] |
| FGFR3-AS1 | 62 tissue samples | High | Poor | [65] |
| TUSC7 | 82 tissue samples | Low | Good | [68] |
| HNF1A-AS1 | 43 tissue samples | High | Poor | [72] |
| 91H | 67 tissue samples | High | Poor | [90] |
| ZEB1-AS1 | 50 tissue samples | High | Poor | [74] |
LncRNA, long noncoding RNA; OS, osteosarcoma; HULC, highly upregulated in liver cancer RNA; UCA1, urothelial carcinoma associated 1; HIF2PUT, hypoxia-inducible factor-2α (HIF-2α) promoter upstream transcript; BCAR4, breast cancer anti-estrogen resistance 4; HOTTIP, HOXA Distal Transcript Antisense RNA; FGFR3-AS1, FGFR3 antisense transcript 1; TUSC7, tumor suppressor candidate 7; HNF1A-AS1, HNF1A-antisense 1; ZEB1-AS1, Zinc Finger E-Box Binding Homeobox 1 Antisense RNA 1; Ref, reference.